Shopping Cart
Remove All
Your shopping cart is currently empty
MGAT2-IN-1 is an orally active monoacylglycerol acyltransferase (MGAT2)inhibitor (human and mouse MGAT2 with IC50 of 7.8 and 2.4 nM , respectively).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $469 | 10-14 weeks | 10-14 weeks | |
| 25 mg | $1,670 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,180 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,480 | 10-14 weeks | 10-14 weeks | |
| 1 mL x 10 mM (in DMSO) | $739 | 10-14 weeks | 10-14 weeks |
| Description | MGAT2-IN-1 is an orally active monoacylglycerol acyltransferase (MGAT2)inhibitor (human and mouse MGAT2 with IC50 of 7.8 and 2.4 nM , respectively). |
| Targets&IC50 | MGAT2 (mouse):2.4 nM , MGAT2 (human):7.8 nM |
| In vivo | In the lipid utilization analysis, MGAT2-IN-1 significantly increases free fatty acid (FFA) and acylcarnitine levels. MGAT2-IN-1 (30 mg/kg) also significantly reduces food intake dose dependently, suppresses BW gains. MGAT2-IN-1 shows anti-diabetic effects in mice[1]. |
| Molecular Weight | 654.01 |
| Formula | C27H21ClF5N7O3S |
| Cas No. | 1800025-30-2 |
| Relative Density. | 1.66 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (191.13 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.